| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,931 |
13,293 |
$2.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,609 |
16,882 |
$2.07M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,612 |
6,599 |
$1.71M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,829 |
2,465 |
$956K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,843 |
1,520 |
$860K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,140 |
1,013 |
$787K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
10,199 |
2,317 |
$445K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,125 |
1,380 |
$433K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
959 |
833 |
$431K |
| 80053 |
Comprehensive metabolic panel |
15,487 |
12,764 |
$379K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
1,876 |
1,438 |
$359K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,643 |
2,421 |
$274K |
| 30140 |
|
149 |
135 |
$267K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
653 |
572 |
$242K |
| G0378 |
Hospital observation service, per hour |
4,444 |
2,086 |
$229K |
| 81001 |
|
11,707 |
10,273 |
$225K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,868 |
4,882 |
$204K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
7,810 |
7,245 |
$115K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,539 |
1,767 |
$92K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,149 |
1,993 |
$90K |
| J3490 |
Unclassified drugs |
446 |
268 |
$79K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,335 |
2,975 |
$73K |
| S0028 |
Injection, famotidine, 20 mg |
1,627 |
1,338 |
$68K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,085 |
1,709 |
$64K |
| 87070 |
|
5,393 |
5,060 |
$60K |
| 59025 |
Fetal non-stress test |
2,699 |
1,884 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,263 |
7,832 |
$51K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
79 |
69 |
$44K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
124 |
116 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,456 |
1,911 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,836 |
2,335 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
2,218 |
2,059 |
$25K |
| 87420 |
|
2,187 |
2,087 |
$24K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
384 |
324 |
$23K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
724 |
674 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,697 |
1,521 |
$22K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
596 |
503 |
$21K |
| 74018 |
|
1,000 |
925 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,733 |
14,970 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
933 |
874 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
5,974 |
5,187 |
$17K |
| 42830 |
|
135 |
104 |
$16K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
610 |
565 |
$15K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
97 |
95 |
$14K |
| 97162 |
|
244 |
201 |
$13K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,562 |
5,629 |
$13K |
| 81025 |
|
1,775 |
1,656 |
$12K |
| A4217 |
Sterile water/saline, 500 ml |
1,028 |
945 |
$12K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
326 |
118 |
$11K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
12 |
$10K |
| 82962 |
|
2,353 |
1,457 |
$10K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,712 |
1,679 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
640 |
521 |
$9K |
| 73630 |
|
585 |
527 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
710 |
603 |
$8K |
| 86850 |
|
1,554 |
1,259 |
$7K |
| 73610 |
|
347 |
311 |
$6K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
198 |
185 |
$6K |
| 87632 |
|
687 |
648 |
$5K |
| 94664 |
|
2,173 |
1,995 |
$5K |
| 85610 |
|
4,504 |
3,725 |
$4K |
| 84702 |
|
1,295 |
1,095 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,973 |
4,832 |
$4K |
| 85730 |
|
4,400 |
3,638 |
$4K |
| 76830 |
Ultrasound, transvaginal |
90 |
82 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,111 |
4,637 |
$4K |
| 84703 |
|
2,653 |
2,458 |
$3K |
| 87040 |
|
3,716 |
2,929 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,608 |
3,791 |
$3K |
| 76641 |
|
43 |
26 |
$3K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
15 |
13 |
$3K |
| A9270 |
Non-covered item or service |
1,579 |
832 |
$3K |
| 82550 |
|
1,874 |
1,535 |
$3K |
| 73130 |
|
219 |
198 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,112 |
7,099 |
$2K |
| 87186 |
|
782 |
689 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
93 |
84 |
$2K |
| 76770 |
|
55 |
54 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,044 |
604 |
$2K |
| 87077 |
|
849 |
786 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,982 |
3,207 |
$2K |
| 12011 |
|
58 |
56 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,756 |
4,163 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,437 |
3,705 |
$2K |
| 73562 |
|
196 |
174 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,154 |
4,932 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,615 |
1,276 |
$1K |
| 76801 |
|
306 |
280 |
$1K |
| 74022 |
|
292 |
275 |
$1K |
| 87631 |
|
13 |
13 |
$1K |
| 84484 |
|
3,188 |
2,268 |
$1K |
| 76857 |
|
147 |
139 |
$1K |
| 83690 |
|
3,035 |
2,695 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
3,714 |
3,420 |
$951.90 |
| 88304 |
|
111 |
96 |
$874.31 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,449 |
4,978 |
$813.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,193 |
1,001 |
$811.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,241 |
2,785 |
$789.36 |
| 86140 |
|
3,831 |
3,522 |
$754.40 |
| 74019 |
|
104 |
104 |
$732.60 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
27 |
24 |
$655.07 |
| 83605 |
|
723 |
576 |
$620.82 |
| 85379 |
|
568 |
511 |
$620.05 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,132 |
1,503 |
$565.71 |
| 83735 |
|
1,427 |
1,128 |
$450.38 |
| 73110 |
|
82 |
79 |
$446.16 |
| 86900 |
|
1,769 |
1,449 |
$433.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
509 |
432 |
$427.42 |
| 85027 |
|
212 |
157 |
$402.82 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,910 |
1,752 |
$387.30 |
| 83880 |
|
295 |
224 |
$344.52 |
| 73090 |
|
12 |
12 |
$305.05 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
815 |
715 |
$303.95 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
596 |
557 |
$286.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
452 |
407 |
$266.81 |
| 86901 |
|
1,769 |
1,448 |
$262.39 |
| 96376 |
|
814 |
467 |
$246.54 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
171 |
161 |
$244.95 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
815 |
634 |
$227.13 |
| 82150 |
|
684 |
651 |
$213.91 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
677 |
449 |
$207.43 |
| 85652 |
|
546 |
492 |
$201.10 |
| 87088 |
|
475 |
408 |
$199.77 |
| 82731 |
|
13 |
12 |
$123.33 |
| 87210 |
|
12 |
12 |
$122.34 |
| 84439 |
|
126 |
108 |
$62.11 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,449 |
1,280 |
$59.25 |
| 94760 |
|
42 |
12 |
$37.14 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
240 |
229 |
$34.95 |
| 73030 |
|
30 |
24 |
$2.37 |
| 84100 |
|
23 |
13 |
$1.57 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
13 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
119 |
112 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
2,073 |
2,003 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
180 |
163 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
497 |
466 |
$0.00 |
| 87045 |
|
17 |
17 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
21 |
18 |
$0.00 |
| 84550 |
|
27 |
24 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
106 |
86 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
42 |
31 |
$0.00 |
| 54161 |
|
12 |
12 |
$0.00 |
| 00920 |
|
12 |
12 |
$0.00 |
| 86308 |
|
84 |
77 |
$0.00 |
| 00160 |
|
133 |
127 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
98 |
72 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
13 |
$0.00 |
| 00126 |
|
73 |
65 |
$0.00 |
| J3590 |
Unclassified biologics |
26 |
26 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
18 |
17 |
$0.00 |
| J1741 |
Injection, ibuprofen, 100 mg |
275 |
258 |
$0.00 |
| 87205 |
|
59 |
49 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
118 |
111 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
18 |
16 |
$0.00 |
| 93971 |
|
14 |
12 |
$0.00 |